Find similar content

Source channel @githubtrending · Post #14992 · Jul 23

#go#aws#azure#cncf#cost#cost_optimization#finops#gcp#k8s#kubernetes#monitoring#opencost#prometheus OpenCost is a free, open-source tool that helps you see and understand the costs of running Kubernetes clusters and cloud services in real time. It breaks down costs by cluster, node, namespace, pod, and more, across multiple cloud providers like AWS, Azure, and GCP, and even supports on-premises setups. This lets you track where your money is going, spot expensive resources, and manage your cloud spending better. It integrates with Prometheus for metrics and offers a user-friendly web interface and APIs for easy cost monitoring and exporting. Using OpenCost helps you control and optimize your cloud and Kubernetes expenses efficiently[1][2][3][4]. https://github.com/opencost/opencost

Hashtags

#go #aws #azure #cncf #cost #cost_optimization #finops #gcp #k8s #kubernetes #monitoring #opencost #prometheus

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment